In the unlikely event of significant copper toxicity, treatment involves IV chelation therapy using EDTA, which binds to excess copper and allows it to be excreted through the kidneys
Due to the availability of several anti-angiogenic agents, we need well-designed prospective randomized trials to optimize therapeutic sequencing
With the recurrence of the disease, long-term crystal load state not cleared, it progressed to the chronic stage, leading to changes in the immune response
Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, Bolaos-Salazar JF, Muoz-Atahualpa E, Postigo-MacDowall M, Corrales-Medina F, Valdivia-Ascua Z, Cuba-Bustinza C, Paredes-Daz S, Villalobos-Tapia P, Chirinos-Pacheco J, Goldberg RB, Chirinos JA